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ABSTRACT

Hepatic steatosis (fatty liver) is increasingly prevalent in the US, and is characterized by
triglyceride accumulation within hepatocytes. This is a direct result of an imbalance between
lipid import, export, de novo lipogenesis, and beta oxidation. Hepatic steatosis can also progress
to nonalcoholic steatohepatitis (NASH) which is characterized by increased hepatocyte damage,
inflammation, and fibrosis. Further progression can lead to liver failure or hepatocellular
carcinoma, requiring liver transplant or causing death. Our lab recently created Mllt3
conditional whole body knockout mice. These mice developed hepatic steatosis and NASH
following Mllt3 deletion. MLLT3 is a master gene regulator that is part of different chromatin
remodeling complexes involved in activating or repressing gene expression. MLLT3 also
contains a YEATS domain histone acylation reader with a preference for crotonylated histone
tails. Crotonylation post-translational modifications are found within promoters and enhancers
of active genes. Thus, MLLT3 functions in epigenetic gene regulation.
We hypothesized that MLLT3 plays critical roles in maintaining liver lipid homeostasis
by regulating expression of specific genes related to the generation of lipid species through its
YEATS domain as well as through its function within specific chromatin modulating complexes.
In order to determine the liver-intrinsic role of MLLT3 in hepatic steatosis, I used both in vitro
and in vivo models. I knocked down MLLT3 in the HepG2 and Huh7 human hepatocellular
carcinoma cell lines. This resulted in rapid accumulation of lipids which suggests a cell-intrinsic
function of MLLT3 in hepatic lipid homeostasis. I analyzed primary liver tissue from
xi

hepatocyte-specific Mllt3 deletion mice that our lab generated. Results from both model systems
indicate that several genes which regulate different metabolic pathways, including de novo
lipogenesis, are affected upon MLLT3/Mllt3 knockdown/knockout. Further study may define
MLLT3 as a novel therapeutic target in attenuation of fatty liver disease.

xii

CHAPTER 1
BACKGROUND
MLLT3 History and Protein Structure
MLLT3, first identified in Mixed Lineage Leukemia as a chromosomal translocation
partner for the MLL gene, is a chromatin reader protein which binds post translationally
modified histone tails through its YEATS domain (Figure 1)1-3. The MLLT3 chromatin reader
domain is called the YEATS domain which is named after the first five proteins that were
discovered to contain this type of structural domain (Yaf9, ENL, AF9, Taf14, and Sas5)4,5. The
structure of the YEATS domain is folded into an eight stranded immunoglobulin fold and binds
to histone tail lysine modifications with its aromatic cage lined with serines6. Initial chromatin
binding assays showed that the YEATS domain had high affinity when binding to acetylated
histone tails, similar to a bromodomain6. More recently, however, it was shown to bind with
higher affinity to crotonylated lysine histone tails (Kcr), thereby distinguishing it from classical
bromodomain function3. A crotonyl molecular structure is a three carbon short chain unsaturated
carboxylic acid, making it one carbon longer then the classical acetylation post-translational
modification. Recent structural studies have shed insights to the structure of the YEATS domain
in the ability to bind both acetylation and crotonylation. Unlike a bromodomain, characterized
by a wall inside of the aromatic cage, thereby restricting the length of a molecule it can bind, the
YEATS domain structure removes this blockade inside the binding pocket, essentially extending
1
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the size of the aromatic cage, thereby allowing it the ability to bind to longer carbon structures7.
In addition to preferential binding to histone crotonylation, the YEATS domain has also been
shown to bind to other post translational modifications such as propionylation and butyrylation3.
However, the MLLT3 YEATS domain has the highest affinity for the crotonyl modification.
Histone crotonylation is evolutionarily conserved from mouse to humans and is a marker for
active promoters and primed enhancers8 . Therefore, MLLT3 YEATS domain binding can mark
chromatin regions with active transcription3. Furthermore, histone acylation is dependent upon
the metabolic state of the cell. Since histone acetyl transferases such as CBP/p300 can catalyze
both acetylation and crotonylation, competition for binding exists between Acetyl-CoA and
Crotonyl-CoA9. It has been shown that growing cells in low glucose will deplete the
concentrations of acetyl-CoA essentially removing the competition for binding for acyl-CoAs
such as Crotonyl-CoA9 .
In addition to the chromatin binding function of MLLT3, several labs, including ours,
have shown the C-terminal domain of MLLT3 to actively play roles in binding four different
gene regulatory complexes (Figure 1)10-12 . Two of these complexes participate in gene
activation, while the other two participate in gene repression. The most well-known of these
complexes is the Super Elongation Complex (SEC). SEC is a multiprotein complex containing
proteins such as RNA Polymerase II, AFF4, and pTEFb, which is involved in releasing paused
RNA Polymerase II following pTEFb-dependent phosphorylation of RNA Polymerase II. It has
been reported that MLLT3 recruits the SEC complex, via direct interactions with AFF4, which in
turn promote RNA Polymerase II to transcribe genes stuck at the transcriptional elongation
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checkpoint13 .
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1-138
YEATS Domain
“Reader” Module:
Crotonylation
Acetylation
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Competitive Binding:
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SEC
DOT1L
Repression
CBX8
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Figure 1. Schematic of MLLT3 Protein Structure. MLLT3 protein structure has the YEATS
domain on the N-terminus with a CTD which binding to various protein complexes at the CTerminus.
Moreover, this pause and release of RNA Polymerase II has been shown to be a rate-limiting
step for transcription in mammalian cells and releasing RNA Polymerase II is dependent upon
this recruitment13. pTEFb is also recruited with the SEC and this protein is responsible for
phosphorylating the carboxyl-terminal domain (CTD) of RNA Polymerase II on serine 2, as well
as phosphorylation of both negative regulators NELF and DSIF, which in turn release one factor
and modulate the other into a positive regulator of transcription14,15 . These phosphorylation
events release RNA Polymerase II from promoter pausing, which allows successful transcription
of the gene14,15 . The other activating complex that MLLT3 has a functional role within is with
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DOT1L. DOT1L, is a methytransferase which is responsible for histone H3 methylation at
lysine 79 (H3K79). This post translational modification has been shown to be a marker of active
transcription16 . One of the repressive complexes that MLLT3 binds is the canonical Polycomb
Repressive Complex 1 (PRC1). The interaction of MLLT3 with this complex is facilitated
through direct interactions with CBX817,18 . Finally, MLLT3 can also participate in a noncanonical repressive Polycomb Complex through its direct interaction with BCOR19,20 .
Interestingly, it has been shown, that binding of AFF4, DOT1L, CBX8, or BCOR to the MLLT3
CTD, which occurs in a mutually exclusive manner, occurs before assimilation of the remainder
of proteins that are involved in those respective complexes.21
Liver Metabolism
The liver is the main organ for metabolic processing and is responsible for maintaining
homeostasis through the cooperation of many proteins and enzymes that maintain the balance
between glucose, lipid, steroid, and cholesterol synthesis, degradation, and storage (Figure 2).
Briefly, after food is digested by the intestines, various metabolites, including glucose, fatty
acids, and amino acids are absorbed and transferred to the liver via the portal vein22 . The fate of
these molecules depends on functionality of the liver. Following eating, glucose is both
converted into glycogen for storage and into fatty acids and other metabolic intermediates22 .
Fatty acids, esterified with glycerol-3-phosphate, are converted into triglycerides (TAGs)
which are then stored in lipid droplets. These triglycerides can also be transferred out of the liver
via very-low-density-lipoproteins, which provide TAGs for other parts of the body22. The liver
also plays critical roles under fasting or starvation conditions. During this time, the liver releases
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TAGs and glucose into the circulation where it is utilized by various tissues22 . During oxygen
deprivation, muscle and cardiac tissues release metabolic intermediates that can be utilized by
the liver to make glucose through gluconeogenesis22. The liver can also break down
triglycerides by beta oxidation, and use them for ketone body formation which can then be sent
to different tissues, such as the brain and heart22. Pathways in liver metabolism involve
gluconeogenesis, glycolysis, TCA cycle, de novo lipogenesis, and beta oxidation. Briefly,
glycolysis involves importing glucose, during the fed state, into the cells and catabolizing it
through multiple enzymatic reactions, into pyruvate22. Subsequently, pyruvate can be shuffled
into The Citric Acid cycle where it is utilized to produce ATP via oxidative phosphorylation, and
alternatively, into the de novo lipogenesis pathway to be converted into fatty acids22 . These
fatty acids can further be processed into to triglycerides necessary for fat storage, and further
elongated, and saturated/desaturated for use in cell membranes and signaling molecules. In
times of starvation, Acetyl-CoA, coupled to oxaloacetate, can be converted back into glucose via
gluconeogenesis pathway and beta oxidation can be used to provide energy via fat storage in the
form of ketone bodies(Figure 2)22.
These essential functions of the liver in regulating metabolic homeostasis are controlled
and regulated by multiple hormones, transcription factors, and nutritional signals22. Two such
factors are Sterol Regulatory Element Binding Protein 1 (SREBF1) and Nuclear Receptor 4A1
(NR4A1). SREBF1 is a transcription factor, embedded inside the endoplasmic reticulum
membrane23 . SREBF1c, the predominant isoform in the liver, is responsible for regulation of

6
genes involved in de novo lipogenesis such as Fatty Acid Synthase (FASN), Acetyl-CoaCarboxylase 1 (ACC1), and Steroyl-CoA Desaturase 1 (SCD1)23 .

Figure 2. Liver Metabolism at a Glance. Overview of Liver Metabolic Pathways indicating
genes in this study that were significantly altered in the knockout mice and knockdown cells
lines.
FASN, for example, is a multifunctional protein that is the second step in de novo lipogenesis,
which synthesizes palmitate from acetyl-CoA and malonyl-CoA24. NR4A1, an orphan nuclear
receptor, also plays roles in lipid metabolism regulation. When overexpressed, this protein has
been shown to decrease the expression of SREBF1c, mitochondrial glycerol-3-phosphate
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acyltransferase (GPAT2), FASN, and the low density lipoprotein receptor (LDLR)25. GPAT2, for
example, converts diacylglycerol into a triacylglycerol; whereas, the converse is observed upon
NR4A1 deletion25. Dysregulation of many enzymes and proteins involved in transport,
synthesis, degradation, and storage, have implications for disease. Lipid transport around hepatic
cells involves fatty acid binding proteins (FABPs). The liver specific isoform, FABP1, plays a
critical role in maintaining the homeostasis of this organ. FABP1 binds long chain fatty acids
and other molecules and functions as a cellular taxi26 . It is involved in intercellular storage and
transport of fatty acids and their acyl-CoA building blocks, promoting utilization of long-chain
fatty acids, and plays a cytotoxic role in binding to excess of fatty acids and other disruptive
molecules27,28. Decreases of this gene can lead to steatosis concomitant with decreased
expression of beta oxidation genes, coupled with increased fatty acid uptake and expression of
lipid droplet genes29,30. Other important lipid transport proteins are involved in lipoprotein
secretion. Very-low-density-lipoproteins are vesicles formed of lipids and protein that a cell uses
to remove excess fatty acids31. Apolipoprotein C-III (APOC3) and Apolipoprotein B (APOB)
dysregulation can lead to failure to form very-low-density-lipoprotein (VLDL), which can lead
to an accumulation of lipid species within the cell31 . Increased expression of genes such as
glycerol-3-phoshphate acyltransferase (AGPAT9) and DGAT2 can lead to an increase in
triglyceride formation, as these genes are directly involved in triglyceride formation. The
gluconeogenic enzymes G6PC and PCK1 can also be implicated in hepatic disease. Decreased
expression of these enzymes could theoretically lead to a higher concentration of acetyl-CoA;
therefore, allowing more of it to pass over to fatty acid synthesis. An excess of lipids leads to an
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increase in lipid storage genes and contributes to increases in cellular stress genes such as
Perilipin 1 and 2 (PLIN1,2) and Uncoupling Protein 2 (UCP2), respectively. PLIN1 is an
enzyme that coats the outside of lipid droplets and regulates their degradation and utilization in
adipocytes, but shows increased expression in NAFLD, while PLIN2 has a similar function in
the liver. Expression of UCP2 is controlled by fatty acid levels and monitors mitochondrial
membrane potential which is an indicator of stress, and as fatty acids accumulate, it is cytotoxic
to the cells, thereby causing stress to the cells32. With potential increases in lipid molecules,
increases in lipid signaling via sphingosine kinase 1 and 2 (SPHK1; SPHK2) could
possibly increase. These kinases generate a bioactive molecule, sphingosine-1-phosphate, which
can modulate cell survival , inflammation, and migration, from the precursors of serine and
palmitoyl-CoA33,34. Therefore, dysregulation in any of these pathways has the potential to lead
to hepatic disease states such a NAFLD and NASH.
NAFLD
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming an epidemic in the world,
with 25% of the population being affected35 . Due to the incidence of this disease increasing
over the last twenty years, NAFLD has become second most common cause for liver transplant
for patients in the United States36 . NAFLD is a result of dysregulation of lipid homeostasis in
hepatocytes which leads to the accumulation of lipids (steatosis) within the cytosol of the
hepatocyte37 . In some patients, simple steatosis is nonmalignant, while in others it can further
progress to nonalcoholic steatohepatitis, which is characterized by hepatocyte ballooning,
inflammation, and fibrosis37 . NASH can further progress to cirrhosis, liver failure, and

9
hepatocellular carcinoma, increasing the need for liver transplants38 . The liver is the critical hub
for lipid homeostasis, involved in generation of new lipid species, export of lipids acquired from
the diet to other tissues in the body, and the acquisition of energy from catabolism39 . These
processes maintain homeostasis through a plethora of interactions among various transcription
factors, hormones, and nuclear receptors38 . The accumulation of lipid within the liver is directly
caused from dysregulation of these processes. Although there is a large body of knowledge
about molecular pathways controlling these processes, the molecular players that regulate this
homeostasis are still not completely understood.
Mllt3 whole body knockout mice display characteristics of liver disease
Previously in the laboratory, conditional whole body Mllt3 knockout mice were generated
which displayed characteristics of liver disease, namely, NAFLD (CSH and NZL, unpublished
data). These mice displayed increased weight and increased in liver size compared to their nonknockout counterparts (Figure 3A). In addition to this, the mice also had increased white
adipose tissue that was present with concomitant increases in cholesterol in the plasma and
triglycerides in the liver (Figure 3B and C). In addition to these features, liver slices stained with
Oil Red O, a lipophilic dye, revealed an increase in lipid accumulation in the Mllt3 whole body
knockout mice as compared to their non-knockout control mice (Figure 3D). Importantly, these
lipid droplets were more numerous and larger compared to those in controls. To determine a
potential liver-intrinsic regulatory function of Mllt3, our lab generated liver specific knockout
mice. They were engineered by crossing the Mllt3flox/flox mice with mice that express Cre
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recombinase regulated by the albumin promoter (Alb-Cre), in which Mllt3 deletion will only
occur within hepatocytes where albumin in normally expressed.

A

B

C

D
Plasma

Liver

mg/liver (gm)

mg/liver (gm)

Cholesterol Triglyceride

Figure 3. Whole Body Mllt3 Knockout Mice Display Fatty Liver Phenotype. Previous Data
from Zeleznik-Le lab indicating in (A), increases of mouse weight compared to controls, in (B),
increases in white adipose tissue, in (C), increases in cholesterol and triglycerides, and (D), Oil
Red O Staining on liver sections.

CHAPTER 2
METHODS
Purification of Plasmid DNAs to be Used For Lentivirus Production
Several plasmid DNAs were used for this research project. Knockdown MLLT3
lentivirus plasmid LLXm3sh1 (referred hereafter as shMLLT3; glycerol stock #1073) and the
control CSIem empty lentiviral vector (referred hereafter as VC; glycerol stock # 1069) were
both gifts from Dr. Tariq Enver (University of Oxford, UK)40 . Both of these also express GFP
from the same vector so infected cells will also express GFP. The lentivirus packaging plasmid,
pCMV-dR8.2 (glycerol stock #1333), and the envelope protein plasmid, pCMV-VSVG (glycerol
stock #1334) were both gifts from Dr. Jiwang Zhang (Loyola University Chicago). These
plasmids were first aseptically quadrant streaked from glycerol stocks in the -80°C onto plates
containing 10mL LB agar containing 20uL ampicillin (Research Products International
Corporation, Cat#: 69-52-3; 50mg/mL) and incubated overnight at 37°C in order to isolate
bacterial colonies used for expansion in liquid media. The following day, isolates were picked
aseptically and added to 200mL of fresh LB (Fischer Bioreagents: BP1426-2; 25g/L), previously
autoclaved, containing 400uL of ampicillin (50mg/mL) and placed in a shaking incubator at
250rpm for 12-16 hours at 37°C. The following day, the DNA was extracted using the Plasmid
MIDI Prep 100 Kit (Qiagen: Cat# 12145). Briefly, the bacteria were spun down at 6,000 x g for
15 minutes at 4°C. The cell pellet was resuspended in 4mL of Buffer P1 into which 4mL of
11
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Buffer P2 was added and the cells were vigorously shaken for 15 seconds and allowed to lyse for
5 minutes at room temperature. Following the lysing, 4mL of Buffer P3 was added to cease the
lysing through incubation on ice for 15 minutes. Following that incubation, the cells were then
centrifuged at >20,000 x g for 30 minutes at 4°C. Next the supernatant was filtered through
gauze into a 50mL falcon tube to facilitated removing further cellular debris. A filter tube
supplied by the Qiagen kit was equilibrated using 5mL of QBT buffer and letting it pass through
the filter by gravity flow. The supernatant in the 50mL falcon tube was then applied to the filter
tube and allowed to flow through by gravity flow. The DNA was now contained within the
filter. The DNA was then washed by applying 10mL of QC wash Buffer. The DNA was then
eluted into a suitable 15mL plasmid screw cap tube with a round base (Sarstedt,
Cat#:60.540.500), by applying 5mL of the elution QF Buffer to the filter tube. Once the DNA
was eluted, it was precipitated from the solution using .7x 100% isopropanol (3.5mL). This tube
was then inverted up and down a few times and centrifuged at >12,000 x g for 30 minutes at 4°C.
A pellet formed on the side of the tube and the supernatant was decanted and the pellet was
washed with 70% ethanol, flicked in order to dislodge the pellet and centrifuged again at
>12,000 x g for 10 minutes at 4°C. Following centrifugation, the supernatant was again
decanted, and the pellet was allowed to dry for 5-7 minutes at room temperature. Finally, the
pellet was resuspended in 300uL of TE (10mM Tris, 1mM EDTA, pH 8.0) and stored at 4°C. for
subsequent experiments.
Transfection of DNA Plasmids Into HEK293T Cells for Lentivirus Production
In order to generate cell lines in which MLLT3 would be stably knocked down as well as
control samples, the first step is to generate the knockdown lentivirus. The lentivirus plasmids
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that will express short hairpin RNAs to knockdown MLLT3 will be packaged into lentivirus
particles. Lentivirus particles will be used to infect target cells. HEK293T cells were utilized as
packaging cells for lentivirus production. These cells were cultured in DMEM media
(Dulbecco’s Modification of Eagle’s Medium with 4.5g/mL glucose and L-glutamine without
sodium pyruvate, Corning Cellgro, Cat #10-017-Cl) with Fetal Bovine Serum (Foundation BTM
Fetal Bovine Serum; FBS; Gemini Bioproducts Cat#: 900-208) and 1% Penicillin-Streptomycin
(100x, Corning, Cat#30-002-Cl) at 37°C and 5% CO2. HEK293T cells (2 x 106) were seeded
into 10cm2 plates (Olympus Plastic Tissue Culture Plate, Tissue Culture Dish, Cat#:25-202) 1624 hours before the transfection commenced. The following day, three to four hours before the
transfection, the media was removed and 10mL of fresh DMEM + 10% FBS and 1% P/S media
was added. Using the CalPhos Mammalian Transfection Kit (Clontech; Cat# 631312), the
following reactions were set up: 10ug of plasmid DNA, 6.5 ug of pCMV-dR8.2 (1333), 3.5ug
pCMV-VSVG (1334), 87uL of 2M Ca+, 700uL 2x HBS, and nuclease free water up to a total
volume of 1.4mL. In a 1.5mL Eppendorf tube, the water, plasmids, and 2M Ca+ was combined
and mixed. The 700uL of 2x HBS was aliquoted into a 5mL snap top conical. The 2x HBS was
then vigorously vortexed as the H2O/plasmid/Ca+ mixture was added dropwise to the 5mL tube.
The resultant mixture was then incubated for 20 minutes in the hood to allow Calcium/Phosphate
complexes to form. Following incubation, the tubes were then gently mixed and 1.4mL of the
DNA/CaPO4 complexes were added dropwise to each dish. The plate was then rocked back and
forth gently to ensure full distribution of the DNA/CaPO4 complexes throughout the plate. The
plates were then incubated overnight at 37°C and 5% CO2. The following day, the media was
removed, and the cells rinsed with 2-3mL of sterile 1x PBS. 5mL of fresh DMEM containing
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10% FBS and 1% P/S was added, and the cells were placed back into the incubator overnight.
The following day, the media was harvested and stored in a falcon tube and stored at 4°C. 5mL
of fresh DMEM was added to the plates and they were incubated overnight. The next day, the
final media was harvested and combined with media of the same construct from the previous
day. The falcon tubes containing virus media were then centrifuged at 500 x g for 5 minutes to
remove cellular debris. The virus was then aliquoted in 1.5mL volumes into screw cap tubes
with an O-ring. The virus was subsequently snap frozen on dry ice and placed into -80°C until
used for experiments.
Transduction of Virus into Hepatocellular Carcinoma Cell Lines
The human hepatocellular carcinoma cell lines HepG2 (HB-8065) and Huh7 (both kindly
provided by Dr. W. Qiu, Loyola University Chicago) were utilized for transduction
experiments41. Cells were thawed from liquid nitrogen and placed in to a 37°C bath for 1-2
minutes and immediately placed into a 15mL falcon tube containing 5-6 mL of DMEM
containing 10% FBS and 1% P/S. The cells were then centrifuged at 1250rpm (~500 x g) for 5
minutes at 22-25C. Following centrifugation, the supernatant was decanted, and the cell pellet
was homogenously resuspended in 10mL of fresh DMEM contain 10% FBS and 1% P/S which
was plated onto a 10cm2 plate and placed into a 37°C incubator with 5% CO2. On the first day
of the transduction, HepG2 cells were seeded at a density of 4.5 x 105 cells per well into a six
well plate (Olympus Plastics Tissue Culture Plate, 6 well Flat/bottom, Cat#:25-105) and allowed
to attach to the plate, with separate plates being used for the vector control and the shMLLT3
knockdown. HuH7 were prepared in a similar fashion, except 1 x 105 cells were seeded. The
following day, the appropriate amount of virus was taken from the -80°C freezer and
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subsequently thawed in a 25°C bath. Aliquots of virus containing the same construct were
combined into the same falcon tube. Polybrene (4mg/mL; 500x stock; Sigma, Hexadimethrine
bromide Cat#: H9268), was added to the virus for a final concentration of 8ug/mL which is
equivalent to 2uL of Polybrene per 1 mL of virus and mixed well. The media in each well of the
six well plate was subsequently removed and 1.5mL of virus + Polybrene was added to each
well. The cells were then centrifuged for 2 hours at 2,225rpm (1000 x g; Beckman GS-6KR
Centrifuge, Indianapolis, IN), at 33-35°C. After the spin, the virus was either removed and 1mL
of fresh DMEM containing 10% FBS and 1% P/S was added, or the virus was left on and 1.5mL
of fresh DMEM containing 10% FBS and 1% P/S was added to the well for a final volume of
3mL in each well. The cells were then placed into a 37°C incubator with 5% CO2 overnight.
The following day, the cells were continued to be cultured or split if necessary. The next day the
cells were prepared for sorting via flow cytometry. Virus-infected cells can be sorted because
the lentiviral vectors also co-express GFP. Briefly, the media was removed from each well and
the wells were washed with 2-3mL of 1x PBS. The 1x PBS was then aspirated and 500uL of
.05% trypsin (.25%Trypsin/2.21mM EDTA 1x [-] sodium bicarbonate Stock, Corning, Cat# 25053-Cl) was added to each well and the cells were allowed to detach for 5-7 minutes in a 37°C
incubator. Following successful detachment of the cells from the plate, 2.0 mL of DMEM was
added to dilute the trypsin and the cells were pelleted in a centrifuge at 1250rpm for 5 minutes at
22-25°C. Following centrifugation, the media was decanted, and the cell pellet was resuspended
in 1mL of DMEM and filtered through a filter (Crosstex International 3½” x 5 ¼” (9 x 13 cm)
Filter Ref#: SCXS ) into a 5mL polystyrene round-bottom FACS tube (Corning, Cat#:352054)
to remove any cell clumps. The FACS tube was then centrifuged at 1250rpm for 5 minutes at
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22-25°C. The supernatant was then removed and the cells were resuspended in 300-500uL of
DMEM prior to flow cytometry. The cells were then sorted using fluorescence activated cell
sorting (FACSAria, Becton Dickinson, San Jose, CA) by their expression of GFP. GFP positive
cells from each construct were sorted into separate collection tubes. After sorting, cells were
seeded at different cell densities in order to perform subsequent experiments.
Oil Red O Staining
Oil Red O is a lipophilic dye which allows positive staining of neutral lipids while
excluding the cell membrane. An Oil O Red stock solution was first prepared by adding Oil Red
O (Sigma: O-0625) to 100% isopropanol at a concentration of 5g/mL and allowed to dissolve
completely overnight. Aliquots of this stock solution were used to prepare working solutions for
experimentation. 16-24 hours before staining, 2 x 105 HepG2 cells were seeded into wells on a
24 well plates (specifics) and DMEM containing 10% FBS and 1% P/S was added to a final
volume of 2mL. HuH7 cells prepared in a similar fashion, except the number of cells seeded
was dependent upon the amount of cells I was able to sort. The amount seeded varied between 1
x 104 to 1 x 105. The plates were placed into the 37°C incubator overnight and the cells were
allowed to attach. DPBS containing Ca2+ and Mg2+ was prepared by .10g/L of CaCl2, .10g/L of
MgCl2•6H2O, .20g/L KCl, .20g/L KH2PO4, 8g/L NaCl, and 2.16g/L of Na2HPO4•7H2O. The
pH was adjusted to 7.3 using a digital pH meter (Accumet Basic AB15 pH Meter Cat#:13-636AB15) by adding HCL. To begin the experiment, the media was removed from wells containing
the cells and the cells were subsequently washed twice with 1-2mL DPBS + Ca2+ and Mg2+, at
pH7.3, to fully remove DMEM. The DPBS was then removed and 4% formaldehyde solution
(Sigma-Aldrich, 37% Formaldehyde solution, Cat#:252549; Added to DPBS with Ca2+ and Mg2+
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to a final concentration of 4%) was added to the cells and the solution was allowed to incubate at
room temperate in the dark for 30 minutes. During this incubation period, an Oil Red O working
solution was prepared. This was done by adding 3 parts of the Oil Red O Stock solution to 2
parts of distilled H2O (3:2 ratio, isopropanol concentration final of 60%) The solution was then
mixed well and allowed to incubate for 15 minutes at room temperature. After the incubation
period, the Oil Red O working solution was filtered through a Whatman #3 (Sigma-, Cat#
10013-090) filter into a clean receptacle and was used within 2 hours. Following fixation by
formaldehyde, the 4% formalin solution was removed from the wells and the cells were washed
with dH2O twice. To facilitate uptake of the dye solution, 500uL of 60% isopropanol was added
to each well and allowed to incubate for 5 minutes at room temperature. The isopropanol was
then removed and 500uL of the working Oil Red O solution was then added to each well. The
cells were then incubated in the Oil Red O solution for 30 minutes at room temperature. After
the incubation, the Oil Red O solution was removed and the cells were subsequently washed 35x with dH2O to remove background staining. 500uL of dH2O was then added to the cells so the
staining would not dry out and were stored at 4°C until photography and quantification. Cells
were then photographed using a microscope (EVOS xL Core Cat# AMEX1000).
RNA Extraction and Purification
To obtain RNA from both the vector control and knockdown cell lines, the media was
removed from the cells and the cells were washed with 5mL of 1x PBS. The PBS was removed
and 1mL of Tri Reagent (Sigma; Cat#T9424)was added. For mouse liver tissue, approximately
100mg tissue frozen at -80°C was placed in dry ice and 1mL Tri Reagent added directly to the
frozen tissue. The tissue was allowed to thaw in the Tri Reagent while being broken into tiny
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fragments. RNA was extracted following the company supplied protocol. Briefly, 1mL of Tri
Reagent, enough volume for up to 5 x 106 cells or 100mg tissue, was added. The cells were then
transferred to a 1.5mL Eppendorf tube and processed immediately or stored at -20°C until
extraction. Prior to extraction, the tubes were allowed to thaw at room temperature, and vortexed
to mix up the solution. Chloroform (Sigma, Cat# C2432; 0.2mL per 1mL of Tri Reagent) was
added to the tubes. The tubes were then shaken vigorously for 15 seconds then allowed to
incubate at room temperature for 2-15 minutes. The duration of incubation time depended upon
the amount of cells being used for the extraction. Following the incubation period, the cells were
then centrifuged at 12,000 x g for 15 minutes at 4°C. Following the spin, the solution was
separated into three distinct layers. A bottom layer containing protein, a middle layer containing
DNA, and a top aqueous layer containing RNA. The top aqueous layer was pipetted into a new
1.5mL Eppendorf, and both the protein and DNA layer was stored at 4°C to be utilized later. To
precipitate the RNA, 0.5mL of 100% isopropanol (Fisher Biosciences Cat# BP2618-4), per 1mL
of Tri Reagent used, was added to the tube and mixed well. The tube was allowed to incubate at
room temperature for 5-10 minutes. To pellet the precipitated RNA, the tube was then
centrifuged at 12,000 x g for 10 minutes at 4°C. After the RNA was pelleted, the supernatant
was removed and the cell pellet subsequently underwent two sequential washes. The first wash
consisted of adding 1mL of 75% ethanol (Decon Laboratories Incorporated, Cat#64-17S) to the
pellet and vortexing the tube to loosen the pellet. The tube was then centrifuged at 7,500 x g for
5 minutes at 4°C. Following the centrifugation, the supernatant was again removed, and the
RNA pellet was washed with 70% ethanol and vortexed to loosen the pellet. The tube was again
centrifuged at 7,500 x g for 5 minutes at 4°C. The pellet was then airdried for 5-7 minutes at
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room temperature. For both HepG2 and HuH7 cell RNA, the pellet was resuspended in 30uL of
nuclease free water and for the mouse liver RNA, the RNA pellet was larger and needed an
increased volume to fully dissolve the RNA pellet that ranged from 100uL to 250uL. RNA was
quantified using a Nanodrop (Thermo Scientific, Nanodrop 2000C Spectrophotometer,
Cat#ND2000). The RNA was then snap frozen on dry ice and stored in the -80°C freezer and
utilized for subsequent experiments.
cDNA Generation
In order to perform gene expression analysis via quantitative PCR, RNA extracted from
cell lines and mouse liver tissue, was converted to cDNA using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems; Cat #4368813). The following PCR reaction
was set up: 2.00uL of 10x RT Buffer, 0.80uL of 25x dNTP Mix (100mM Stock Solution),
2.00uL of 10x RT Primers, 4.20uL Nuclease free water, 2ug of RNA, and 1uL of Reverse
Transcriptase (50U/µL). The kit components consist of 10uL of the total 20uL reaction. The
other 10uL came from the RNA that was aliquoted in a tube at a concentration of 2ug and
brought up to a final volume of 10uL with nuclease free water. The 20uL reactions were placed
into 100uL (MidSci, Pryme PCR Ergonomic Tubes, Cat#B77201) PCR tubes and placed into a
thermocycler (Applied Biosystems Veriti 96 Well Fast Thermal Cycler, Cat#:4375786). The
following cycling conditions were used to maximize the efficiency and output of the reaction:
one cycle at 25°C for 10 minutes, one cycle at 37°C for 2 hours, and one cycle at 85°C for 5
minutes and a hold at 4°C. The samples were then removed from the thermocycler and stored in
the -20°C until further use.
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Quantitative PCR Analysis
qPCR was performed on cDNA extracted from vector control and MLLT3 knockdown
cells from HepG2 and HuH7 cells a well as from control and Mllt3 knockout liver tissue. The
TaqMan Fast Advanced Master Mix (Applied Biosystems; Cat # 4444556) was used for these
experiments and the following qPCR reaction was set up: 10uL of 2x TaqManÒ Fast Advanced
Master Mix, 1uL 20x Gene Primer/Probe (All Probe: .5uM Stock; All Primers: 1uM , 1uL 20x
housekeeping gene primer/probe, 1uL of cDNA, and 7uL of dH2O. Reactions were set up into
individual master mixes and subsequently added to reaction tubes containing necessary volumes
for a triplicate reaction. The cDNA was then added to these tubes in volumes necessary for
triplicate reactions. These tubes were then aliquoted in 20uL volumes into a 96 fast well
(MidSci qPCR Plates 96 x.1mL Cat#: AVT3890) plate in triplicate. Following placement of
protect film over plate (MidSci Thermal Seal,Cat# TS-Rt2RR-100) , the plate was loaded into a
Quantstudio 6 Flex machine (Applied Biosystem). On the software (Quantstudio Real-Time
Software) the following experimental properties were set up: quantstudio6, fast 96 well,
comparative Ct, taqman reagents, and a fast 96 well. Target genes were labeled and the correct
fluorophore Was chosen. The samples were correctly added to the sample name list, and the
wells were assigned with the correct samples and gene name that was setup before the reaction
was set up. In some cases, a specific gene reaction was duplexed with a housekeeping gene
(different color probe fluorescence) that acted as a normalizing control. The following cycling
conditions were set up: a hold stage at 50°C for 2 minutes, a hold stage at 95°C for 20 seconds,
and 40 cycles of the PCR stage at 95°C for 1 second and 60°C for 20 seconds. Comparative Ct
valued were normalized to the housekeeping gene (either from duplexes reaction or from
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independent reaction). DDCt values were calculated by comparisons between the experimental
sample Ct and the control sample Ct.
RNA Sequencing
To gain genome-wide information regarding MLLT3-dependent gene expression, RNA
sequencing analysis was performed on HepG2 cells with MLLT3 knockdown (and vector
control) at both 48 hours and 72 hours post transduction. The RNA was extracted from the cells
following the protocol described above. Once the RNA was obtained, it was further processed
and RNA Integrity Number (RIN) determined prior to sending the samples for RNA-seq. The
RIN is a method to determine the integrity of the RNA and is determined by using the ratio of
the 28s to 18s rRNA, as measured by a bioanalyzer. To further clean the RNA from possible
DNA contaminants, the Turbo DNA-free Kit (Ambion Cat#: AM1907) was used to remove
DNA contamination. RNA was aliquoted into a fresh tube at a concentration of 2ug in 50mL of
nuclease free water. To remove contaminating DNA, 0.1x the total volume (5uL in this case) of
the DNAse buffer and 1uL of DNAse enzyme was added to the sample tube and mixed well.
The tubes were then placed into a 37°C bath and incubated for 30 minutes. Following the
incubation, the tubes were removed from the bath and 5uL of DNAse inactivating reagent ,
which binds DNase and divalent cations, which can then be pelleted, was added to the tubes.
The tube was incubated for 5 minutes and during this time the tube was flicked 2-3 times to
redistribute the inactivating reagent. Following this incubation period, the tubes were
centrifuged at 12,000 x g for 1.5 minutes, allowing the DNAse inactivating reagent to pellet on
the side of the tube. After the supernatant was carefully pipetted into a fresh tube and
subsequently underwent analysis for purity and integrity in a Agilent 2100 Bioanalyzer using the
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Agilent RNA 6000 Nano Reagents Kit (Agilent Cat# 5067-1511). The protocol that was
provided by the company was followed to ensure proper analysis. First, the reagents on the kit
were removed from the 4°C, and were allowed to equilibrate for 30 minutes to room temperature
but kept in the dark. Next, 500uL of RNA 6000 Nan Gel Matrix was aliquoted into a Snap Filter
Tube (Agilent Cat#5185-5990) and centrifuged at 500 x g for 10 minutes. Following
centrifugation, 65uL of that filtered gel was aliquoted to a fresh .5mL tube provide by the
company (Aglient, Safe-Lock Eppendorf Tubes PCR Clean for gel-dye mix). Next, the RNA
6000 Nano Dye Concentrate was vigorously vortexed for 10 seconds and then briefly spun
down. 1uL of the dye was then aliquoted to the .5mL tube containing the 65uL of filtered gel.

Table 1: qPCR Primers Used For Mice Gene Expression Analysis
Gene
Polr2a Primer
1
Polr2a Primer
2
Polr2a Probe
Col1a1
Primer 1
Col1a1
Primer 2
Col1a1 Probe
Apoc3 Primer
1
Apoc3 Primer
2
Apoc3 Probe

Species
Mus
musculus
Mus
musculus
Mus
musculus
Mus
musculus
Mus
musculus
Mus
musculus
Mus
musculus
Mus
musculus
Mus
musculus

Sequence (5`-->3`)
CAG GGT CAT ATC TGT CAG CAT G
GGT CCT TCG AAT CCG CAT C
/5HEX/CCA CCA CCT /ZEN/CTT CCT CCT CTT GC/3IABkFQ/
CAT TGT GTA TGC AGC TGA CTT C
CGC AAA GAG TCT ACA TGT CTA GG
/56-FAM/CCG GAG GTC /ZEN/CAC AAA GCT GAA
CA/3IABkFQ/
TGT CAG TAA ACT TGC TCC AGT AG
AGG AGT CCG ATA TAG CTG TGG
/56-FAM/AGT GAT TGT /ZEN/CCA TCC AGC CCC
TG/3IABkFQ/

Col3a1
Primer 1
Col3a1
Primer 2

Mus
musculus
Mus
musculus
Mus
Col3a1 Probe musculus
Fabp1 Primer Mus
1
musculus
Fabp1 Primer Mus
2
musculus
Mus
Fabp1 Probe musculus
G6pc Primer Mus
1
musculus
G6pc Primer Mus
2
musculus
Mus
G6pc Probe
musculus
Agpat9
Mus
Primer 1
musculus
Agpat9
Mus
Primer 2
musculus
Mus
Agpat9 Probe musculus
Mllt1 Primer Mus
1
musculus
Mllt1 Primer Mus
2
musculus
Mus
Mllt1 Probe
musculus
Srebf1 Primer Mus
1
musculus
Srebf1 Primer Mus
2
musculus
Mus
Srebf1 Probe musculus
Mllt3 Primer Mus
1
musculus
Mllt3 Primer Mus
2
musculus
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CCA GGG TCA CCA TTT CTC C
CCA ACC CAG AGA TCC CAT T
/56-FAM/ACA GCC TTC /ZEN/TAC ACC TGC TCC
TG/3IABkFQ/
CAC CAT TTT ATT GTC ACC TTC CAG
TGG TCC GCA ATG AGT TCA C
/56-FAM/ACG ACT GCC /ZEN/TTG ACT TTT TCC CCA
/3IABkFQ/
GAC CAT AAC ATA GTA TAC ACC TGC T
GAC ACC GAC TAC TAC AGC AAC
/56-FAM/AGC AGT TCC /ZEN/CTG TCA CCT GTG
AG/3IABkFQ/
CAG ATG CAC CAG CTC ACT C
CTA TTG CTT CCT GCT ACC TCT G
/56-FAM/TCA CCC TGG /ZEN/CTT TCA TTG GGA TCA
/3IABkFQ/
CCG ACT CCT CCA CTT TGT AG
CTG AGC AGT GTG ACA TCC AG
/56-FAM/CCT AAA CCC /ZEN/AAG CGT GTG TGC AAG
/3IABkFQ/
CTC GCT CTA GGA GAT GTT CAC
TCT GCC ACC CTG TAG GTC
/56-FAM/CCC AGT CCC /ZEN/CGT CCA CAA AGA AAC
/3IABkFQ/
CCC ACC TTA CAA GGT AGA AGA G
GCC TTC AAG ATG CAG GAA TAA G

Mllt3 Probe

Mus
musculus

/56-FAM/ACG CTG GCT /ZEN/TCA TCT TGC CAA TTG
/3IABkFQ/

Table 2: qPCR Primers Used For Human Gene Expression Analysis
Gene
B2M Primer
1
B2M Primer
2

Species
Homo
sapiens
Homo
sapiens
Homo
B2M Probe
sapiens
FABP1
Homo
Primer 1
sapiens
FABP1
Homo
Primer 2
sapiens
Homo
FABP1 Probe sapiens
LDLR Primer Homo
1
sapiens
LDLR Primer Homo
2
sapiens
Homo
LDLR Probe
sapiens
NR4A1
Homo
Primer 1
sapiens
NR4A1
Homo
Primer 2
sapiens
Homo
NR4A1 Probe sapiens
RXRA Primer Homo
1
sapiens
RXRA Primer Homo
2
sapiens
Homo
RXRA Probe
sapiens
SPHK1
Homo
Primer 1
sapiens

Sequence (5`-->3`)
ACC TCC ATG ATG CTG CTT AC
GGA CTG GTC TTT CTA TCT CTT GT
/5HEX/CCT GCC GTG /ZEN/TGA ACC ATG TGA
CT/3IABkFQ/
ACC AGT TTA TTG TCA CCT TCC A
GCA CTT CAA GTT CAC CAT CAC
/56-FAM/AAC CAC TGT /ZEN/CTT GAC TTT CTC CCC
TG/3IABkFQ/
GTT GTT GTC CAA GCA TTC GTT
CCA ACA AGT TCA AGT GTC ACA G
/56-FAM/TCT AGC CAT /ZEN/GTT GCA GAC TTT GTC CAG
/3IABkFQ/
GGC AGA TGT ACT TGG CGT T
GCT GTG TGT GGG GAC AA
/56-FAM/TGA AGA AGC /ZEN/CCT TGC AGC CCT
C/3IABkFQ/
CGG CAT GTC CTC GTT GG
TGG GCA TGA AGC GGG AA
/56-FAM/AGC GTG GCA /ZEN/AGG ACC GGA A/3IABkFQ/
CCG TTC ACC ACC TCG TG
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SPHK1
Primer 2
SPHK1 Probe
SPHK2
Primer 1
SPHK2
Primer 2
SPHK2 Probe
UCP2 Primer
1
UCP2 Primer
2
UCP2 Probe
FASN Primer
1
FASN Primer
2
FASN Probe
MLLT1
Primer 1
MLLT1
Primer 2
MLLT1 Probe
SREBF1
Primer 1
SREBF1
Primer 2
SREBF1
Probe
MLLT3
Primer 1
MLLT3
Primer 2
MLLT3 Probe

Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
Homo
sapiens
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TTC ACG CTG ATG CTC ACT G
/56-FAM/CCC GTC TCC /ZEN/AGA CAT GAC CAC
C/3IABkFQ/
CCC GTT CAG CAC CTC AT
CCT TCA ACC TCA TCC AGA CAG
/56-FAM/CGT GAC GAT /ZEN/GCC ATC CCA CTC
A/3IABkFQ/
AAT CGG ACC TTT ACC ACA TCC
GTT CTA CAC CAA GGG CTC TG
/56-FAM/CTC CTA GCA /ZEN/GGC AGC ACC ACA
/3IABkFQ/
GAC TGT GTC CTT GGA GTT GTG
CTC GCT GCC TAC TGG AG
/56-FAM/CCG TGG GCT /ZEN/TGT CCT GGG A/3IABkFQ/
GTG TGG CTT GGA GGT CTT G
TTC CAC TCT CTG CCT TCT CT
/56-FAM/CGT GGG ATG /ZEN/GTT TGG TCT TCT TGG
G/3IABkFQ/
CTG CTT GAG TTT CTG GTT GC
CTA CCG CTC CTC CAT CAA TG
/56-FAM/TTA TTC AGC /ZEN/TTT GCC TCA GTG CCC
A/3IABkFQ/
ACC AGC ATA CCC AGA TTC TTC
GAG CAC AGT AAC ATA CAG CAC T
/56-FAM/TGG ATC TTT /ZEN/GCA CAC TCT TTT TGG
CC/3IABkFQ/
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The tube containing the dye and the gel was then vortexed well to ensure proper mixing and
centrifuged at 13,000 x g for 10 minutes at room temperature. Once this was finished the tube
was kept in the dark and used within the day. Following this, a tube containing the RNA 6000
NanoLadder, was thawed from the -80°C and the RNA nanochip was set up. Initially, the
Bioanalyzer needed to be cleaned. So 350uL of RNAse Zap (ThermoFisher Scientific
Cat#:AM9780) was added to a nanochip labeled “RNAse Zap” and placed into the bioanalyzer
for 1 minute. To wash that off, 350uL of nuclease free water was added to a different nanochip
and placed into the bioanalyzer for 10 seconds and then removed. The lid on the bioanalyzer
was kept open to ensure that the water would evaporate before the sample nanochip was added.
Briefly, the nanochip was set up by placing it into the chip priming station and adding 9uL of
spin filter gel and dye to the well on the chip labeled by G that was surrounded by a circle.
Following addition of the 9uL, a syringe was used to put pressure onto that well. The syringe
was ensured to be above or at 1mL, the syringe applied to the well and pushed all the way into
the well for 30 seconds exactly. Immediately at 30 seconds, the pressure of the syringe was
released and 5 seconds was allowed to pass. After the five seconds, the syringe was placed back
to 1mL and removed from the well. After this, two more wells labeled “G” had 9uL of the spin
filter gel added to them. Following this, 5uL of the RNA Nano Maker was added to the wells
labeled 1-12 and the well labeled with a ladder. Next, 1uL of the ladder added to the well
labeled ladder. Next 1uL of sample was added to each of the sample wells. If there were not
enough samples to fill all sample wells, 1uL more of the RNA Nano Marker was added to each
unused sample well. Once this is completed the nanochip was then inserted into IKA vortex
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mixer and allowed to vortex the solutions around the chip for 1 minute at 2400 rpm. Finally, the
nanochip had to be used within 5 minutes of this and was placed into the bioanalyzer and
analyzed using the company provided software.
Albumin-Cre Mice
The Mllt3flox/flox mice in our lab were crossed with mice that express Cre recombinase only in the
liver (B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn/J), also called Albumin-Cre (Alb-Cre) mice. Mice that are
Mllt3flox/flox; Alb-Cre will delete Mllt3 only in liver cells. The control mice used were age and
sex-matched and possessed a Mllt3flox/flox genotype. Genotypes were determined by extraction of
DNA from the tails with subsequent PCR using specific primers (Table 2) which would indicate
the presence or absence of the Mllt3 alleles. After the mice were sacrificed, the liver was
dissected out and split up for subsequent experiments. A liver chunk was embedded in paraffin
which was sent to a pathologist for hematoxylin and eosin staining which would enable
observation of any Mllt3del effect on the cells. Another section was frozen in freezing material
and saved at -80°C for subsequent cryosectioning after which the liver samples are stained with
Oil Red O solution and hematoxylin in order to determine lipid accumulation. Finally, sections
of liver were stored for subsequent RNA extraction and gene expression analysis.
Cell Culture
All cell lines were cultured in DMEM containing 10% Fetal Bovine Serum and 1%P/S
and cultured on 10cm2 dishes. As cells got confluent the media was removed and the cells
washed with 5mL 1x PBS. The PBS was removed and 2mL of .05% trypsin was added and the
cells were placed into a 37°C incubator to detach for 5-7 minutes. 6 mL of DMEM (containing
10% FBS and 1%P/S) was then added to each plate to dilute the trypsin and the cells were
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pipetted into a falcon tube and centrifuged at 1250rpm for 5 minutes at 22-25°C. Once the cells
were pelleted, the media was removed and the cells were resuspended in 1mL of DMEM +
10%FBS and 1%P/S. HEK293T cells were split at a culturing ratio of 1:10 (100uL) and both
HepG2 and HuH7 cells were split at a culturing ratio of 1:5 (200uL) into a fresh 10cm2 plate
containing 10mL of fresh DMEM with 10% FBS and 1% P/S. Cells that were utilized from this
step that were needed for RNA or other experimentation, were counted using a hemocytometer
first, and the cell number determined for plating for different experiments.

Table 3. Primers Used For Genotyping Alb-Cre Mice
Gene
AlbuminCre F
AlbuminCre R
Mllt3 wt F
Mllt3 wt R

Species
Mus
Musculus
Mus
Musculus
Mus
Musculus
Mus
Musculus

Sequence (5`-->3`)
TAC CTG GAA AAT GCT TCT GT
TGA TCT CCG GTA TTG AAA CT
TGC TCA GAA ACA GGA CAG AGT
CCT AGG CAG CGA GGA AGT TT

CHAPTER 3
RESULTS
To Determine Liver Intrinsic Role of MLLT3
Knockdown of MLLT3 in Human Hepatocellular Carcinoma Cell Lines
As mentioned in the background, whole body Mllt3 knockout mice were generated and
these mice displayed characteristics of obesity and hepatic steatosis. These characteristics
included increased total body weight, increased liver weight, increased white adipose tissue,
increased triglycerides as determined by Oil Red O staining, and concomitant increases in
expression of some relevant metabolic genes expression in Mllt3 whole body knockout mice as
compared to the control littermates. These observations led us to hypothesize a liver intrinsic role
for MLLT3 in liver metabolic homeostasis.
To investigate the role of MLLT3 within liver cells in vitro, lentivirus particles
containing either the vector control construct or the shMLLT3 construct were packaged utilizing
HEK293T cells. In addition to containing a short hairpin RNA that targets MLLT3 in the
shMLLT3 construct, both plasmids also code for GFP. This enables visualization of the cells
infected by the viruses as well as determination of the efficacy of virus infection. To determine
transfection efficiency, the packaging HEK293T cells were visualized under an EVOS
microscope to determine the amount fluorescence present (Figure 4A and B). The vector control
transfected cells had a more dim GFP signal than the MLLT3 knockdown cells (Figure 4B).
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B

Figure 4. GFP Expression in HEK293T Cells Following Transfection of Lentivirus
Plasmids. HEK293T cells expressing GFP as visualized through fluorescence microscopy 72
hours after transfection with plasmids for lentivirus particle production. (A) cells expressing
the shMLLT3 construct, and (B) cells expressing the VC construct. Bar indicates 400um.
Successful transduction of lentivirus particles containing the vector control and the shMLLT3
knockdown constructs respectively, into the human hepatocellular carcinoma cell line, HepG2,
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was confirmed by fluorescence microscopy. To obtain purified cell cultures with all cells
expressing the vector control or the shMLLT3 construct, 48 hours after transduction these cells
were sorted using fluorescence activated cell sorting (FACS). In order to determine the
transduced cells from the untransduced cells, non-infected HepG2 cells were initially utilized to
set the sorting gates to control for any cell autofluorescence. Based on the autofluorescence
signal, conservative gating was set; cells displaying greater than a 103 GFP (FITC) signal were
selected for sorting and subsequently collected. This enabled the collection of only GFP+ cells
that express the constructs of interest, both the shMLLT3 and the csiem, respectively (Figure
5A). As I observed in the packaging 293T cells (above), the vector control transfected HepG2
cells had a more dim GFP signal than the MLLT3 knockdown cells (Figure 5B). Interestingly,
following MLLT3 knockdown, HepG2 cells started to display morphological characteristics that
were different compared to the vector control cells. These included weaker adherence, a more
raised appearance, slower initial proliferation, and slower adherence to the plate (Figure 5B). To
confirm knockdown of MLLT3 in the sorted GFP+ HepG2 cells, quantitative reversetranscriptase PCR (qRT-PCR) was performed. RNA extracted from different times following
transduction (72 hours and 1 to 5 weeks), was converted to cDNA and subjected to qRT-PCR.
Expression of b-2 microglobulin (B2M) was used to normalize MLLT3 expression. I confirmed
that MLLT3 expression was decreased to approximately 20% of the levels observed in VC
HepG2 cells (Figure 6). Decreased MLLT3 expression was maintained throughout the time
course, but was around 40% of control levels by 5 weeks post-transduction (Figure 6). Another
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Figure 5. Flow Cytometry Plots Indicating Gating Strategy For Sorting GFP+ Cells and
Morphological Differences Displayed by shMLLT3 Cells. (A) Flow cytometry plots
indicating the gating utilized to sort for pure populations of GFP expressing cells. (B) Phase
contrast and fluorescence microscopy images of the VC HepG2 cells (top) and shMLLT3 HepG2
cells (bottom) at one week post infection.
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Figure 6. qRT-PCR to Determine MLLT3 Knockdown Efficiency in Transduced, Sorted
HepG2 Cells. RNA isolated from transduced, sorted HepG2 cells was converted to cDNA and
used for qRT-PCR. MLLT3 expression was compared to expression of B2M, and normalized to
MLLT3 expression in VC-transduced cells. Data displays and N=1
human hepatocellular carcinoma cell line, HuH7, was subjected to viral transduction to
determine if MLLT3 knockdown produced similar results as I found for HepG2 cells. HuH7
cells were transduced with lentivirus containing either vector control or shMLLT3 constructs.
HuH7 cells were transduced with lentivirus containing either vector control or shMLLT3
constructs. As with the HepG2 cells, 48 hours following transduction the HuH7 cells were
subjected to sorting by FACS. Wild type HuH7 cells were used to determine the amount of
autofluorescence to help set the gates for sorting (Figure 7A). HuH7 transduced cells displaying
a GFP fluorescence of greater then 102 FITC expression were sorted and collected, giving a pure
culture of transduced cells to propagate and study (Figure 7B). Similar to the HepG2 MLLT3
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knockdown cells, the HuH7 MLLT3 knockdown cells also displayed morphological
characteristics that were similar to the HepG2 cells with MLLT3 knockdown. These included
weaker and slower adherence to the culture plate, raising of the cells over time, and slower initial
proliferation. experiments.
A

B

Figure 7. Flow cytometry plots for HuH7 cells expression of shMLLT3 and control
constructs. (A) Flow cytometry autofluorescence plots for untransduced HuH7 cells. (B) flow
cytometry plots for transduced HuH7 for the VC (left) and shMLLT3 (right). Sorting gates were
set based on the autofluorescence from the untransduced cells (A)
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Figure 8. MLLT3 expression levels in HuH7 cells following transduction. qPCR data from
HuH7 knockdown cells indicating the expression levels of MLLT3 throughout the designated
time course. Data Displays an N=2 for both 48 and 72 hr and an N=1 for 1wk timepoints.
To determine the extent of MLLT3 knockdown, RNA was extracted from cells at 48hr, 72hr, and
1 week following transduction, converted to cDNA and subsequent qRT-PCR was performed. I
determined that MLLT3 was knocked down to approximately 40% of control levels and
maintained throughout the time course of study (Figure 8). These results confirm MLLT3
knockdown in both HepG2 and HuH7 cells that were utilized for subsequent experiments.
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Determine Whether Lipid Accumulates Following MLLT3 Knockdown in Human HCC
Cell Lines
To determine lipid accumulation in in vitro studies, Oil Red O (ORO) staining was
employed to determine the extent of lipid accumulation in these cells. Remarkably, staining
revealed an increase of lipid droplets in the shMLLT3 HepG2 cells compared to the vector
control cells as early as 72 hours (Figure 9). Interestingly, these cells were grown in normal
DMEM media, with no addition supplementation of glucose, palmitate or other lipid promoting
factors. Subsequent staining on cells at one week also displayed an increase in lipid droplet
formation within the shMLLT3 cells compared to the vector control cells (Figure 10) It is
important to note that the shMLLT3 HepG2 cells contained both an increase in the number of
lipid droplets as well as an increase in the size of some lipid droplets as compared to the vector
control cells. The other in vitro cell line, HuH7, was also subject to Oil Red O Staining, to see if
the phenotype was maintained across two different cell types. Again, staining of the shMLLT3
HuH7 cells revealed an increase in hepatic lipid droplets as quickly as 72 hours post transduction
(Figure 11). This steatosis phenotype was maintained for the time course of this experiment.
Similar to the shMLLT3 HepG2 cell lines, the shMLLT3 HuH7 displayed both an increase in the
number of lipid droplets as well as an increase in the sizes of some droplets. These results
suggest a possible liver intrinsic role of MLLT3 within hepatocytes in regulating lipid
homeostasis.
Determine Mllt3 Expression in Liver Tissue From Mice With Liver-Specific Deletion of
Mllt3
Previously in the lab, whole body Mllt3 knockout mice were generated that displayed
characteristics of non-alcoholic fatty liver disease (NAFLD).
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Figure 9. Oil Red O Staining in HepG2 Cells Show Increases in Lipid Accumulation at 72
Hours Following MLLT3 Knockdown. Two independent experiments demonstrated increased
lipid accumulation in MLLT3 knockdown HepG2 cells (bottom in A and B) compared to the
vector control (top in A and B), viewed at 400x magnification. Cells were stained with Oil Red
O to visualize lipid droplets (red color).
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Figure 10. Oil Red O Staining in HepG2 Cells Display Increased Lipid Accumulation At
One Week After MLLT3 Knockdown. Composite images from MLLT3 knockdown HepG2
cells one week after transduction. Cells stained with Oil Red O are shown to have increased
levels of lipid accumulation (red color). Images at 400x magnification.
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Figure 11. Oil Red O Staining of HuH7 cells 72 hours following MLLT3 knockdown
display increased lipid accumulation. Composite image of Oil Red O stained, MLLT3
knockdown HuH7 cells showing increased lipid accumulation compared to the vector control
cells.
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These include increased liver size, weight, and hepatic steatosis. In order to gain an
understanding of the liver-intrinsic role of Mllt3, mice were engineered in our lab to specifically
delete Mllt3 within hepatocytes. This was accomplished by breeding Mllt3flox/flox mice with mice
that express Cre recombinase under regulation of the Albumin promoter (Alb-Cre). I participated
in genotyping mice from the breeding to determine mice with homozygous, Mllt3flox/flox, and
Mllt3flox/flox; Alb-Cre mice. These mice were used for subsequent experimentation.
For my experiments, I used control and knockout littermates. These include male mice
pairs 888/900, 865/863, 898/851, and 853/847 and female mice pairs 894/896, 890/893, 927/935,
929/895, and 868/846 (Table 4).
In order to determine the effect of Mllt3 knockout on Mllt3 expression within the livers
from Mllt3flox/flox; Alb-Cre mice, qRT-PCR was performed on RNA converted to cDNA. Mllt3
expression is displayed from four pairs of males and 4 pairs of female mice, taken at 5.3wks,
10wks, 13wks, and 21wks. My results indicate that Mllt3 expression was significantly decreased
to approximately 12.7% in knockout as compared to control mice livers (Figure 12). It is
important to note that although this is a full knockout, it takes place in hepatocytes only, as they
are the only cell type that express albumin. Other cells present in the liver, such as Stellate and
Kupffer cells, do not express albumin, and therefore, some remaining expression of Mllt3 was
observed during qRT-PCR analysis.
Determination of Lipid Accumulation Following Mllt3 Knockout in Mice Livers
Frozen liver sections from the Albumin-Cre liver specific Mllt3 knockout mice and their
wild type counterparts were sectioned and stained with Oil Red O to determine the extent and
any differences in lipid accumulation between them. Oil Red O staining revealed an increase in
hepatic lipid accumulation in the livers from Albumin-Cre Mllt3 knockout mice compared to the
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wild type mice, for all ages of mice assessed (Figures 13-15). As observed with the human HCC
cell lines, the lipid droplets were both increased in amount and increased in size as compared to
the controls. It is important to note that, depending on the liver section, there was increased lipid
staining in certain parts while others lay barren with no staining at all. Further investigation into
this phenomenon is necessary. All together these results indicate that overall, liver specific Mllt3
knockout results in in mice that display hepatic steatosis. This suggests a hepatocyte intrinsic
role of Mllt3 within the liver.
Table 4. List of Mouse Age and Sex Matched Pairs

Mice #

Sex
888 M
900 M
865 M

Cre
+/+
Alb-Cre
+/+

MLLT3
flox/flox
flox/flox
flox/flox

863
898
851
853
847
896
894
890
893
927
935
929
895
868
846

Alb-Cre
+/+
Alb-Cre
+/+
Alb-Cre
+/+
Alb-Cre
+/+
Alb-Cre
+/+
Alb-Cre
+/+
Alb-Cre
+/+
Alb-Cre

flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox
flox/flox

M
M
M
M
M
F
F
F
F
F
F
F
F
F
F

Age at Sac (in
Wks)
5.3
5.3
10
10
13
13
21
21
5.3
5.3
5.3
5.3
10
10
13
13
21
21
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Figure 12. Graph of Mllt3 expression in Albumin-Cre Mouse Livers vs. Control Mouse
Livers. Mllt3 expression in liver tissue isolated from Mllt3flox/flox, and Mllt3flox/flox; Alb-Cre mice.
Expression was normalized to RNA Polymerase II plotted relative to control mice. N=10 of
each genotype.
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Figure 13. Oil Red O Staining of Albumin-Cre Mice livers at 5.3wk display an increase of
lipids. Oil Red O Staining of Mllt3flox/flox; Alb-Cre and control Mllt3flox/flox male mice liver
sections. Livers were isolated from mice at age 5.3 weeks, and the livers immediately processed
for freezing. Staining was performed on frozen sections. (A) Livers from male mice at
400x(left) and 1000x(right) magnification, and (B) livers from female mice at 400x(left) and
1000x(right) magnification. Scale bars are 50µm (left) and 20µm (right)
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Figure 14. Oil Red O Staining of Livers From Male Mllt3flox/flox; Alb-Cre Mice Aged 10
Weeks Reveal Increased Lipid Accumulation Compared to Controls. Oil Red O Staining of
Mllt3flox/flox; Alb-Cre and control Mllt3flox/flox male mice liver sections. Livers were isolated from
mice at age 10 weeks, and the livers immediately processed for freezing. Staining was
performed on frozen sections. Livers from male mice at 400x(left) and 1000x(right)
magnification. Scale bars represent 50µm (left) and 20µm (right)
MLLT3 Dependent Gene Expression in the Liver Cells
Understanding the role MLLT3 plays in the regulation of lipid homeostasis is critical to
understanding any role that MLLT3 may have in NAFLD. Increases in lipid accumulation as
soon as 72hrs post MLLT3 knockdown suggest that MLLT3 must play a role in regulating
specific genes that control these processes or directly affecting the expression of genes that
regulate and modulate the cell responses to its environment.
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Figure 15. Oil Red O Staining in Female Mllt3flox/flox; Alb-Cre and Control Mllt3flox/flox Mice
Aged 13 Weeks Reveal Increased Lipid Accumulation Following Mllt3 Knockout. Oil Red
O Staining of Mllt3flox/flox; Alb-Cre and control Mllt3flox/flox female mice liver sections. Livers
were isolated from mice at age 10 weeks, and the livers immediately processed for freezing.
Staining was performed on frozen sections. Livers from female mice at 400x(left) and
1000x(right) magnification. Scale bars represent 50µm (left) and 20µm (right).
To begin to understand this role gene expression analysis is necessary to determine genes that are
either upregulated or downregulated upon MLLT3 knockdown. Therefore, RNA extracted from
HepG2 cells 48hr and 72hr after MLLT3 knockdown were prepared for RNA-sequencing by
Novogene Corporation, a company that performs multiple types of next-generation sequencing,
including RNA-sequencing. Data received back from Novogene indicated that over 1200 genes
were differentially expressed between the 48hr knockdown cells and the vector control cells
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(Figure 16A). In addition, gene ontology analysis indicated that pathways that were significantly
downregulated included triglyceride-rich plasma lipoprotein particle, very-low-densitylipoprotein particle, and various other pathways that utilize lipid species within the cell (Figure
16B). Among gene ontology terms that were upregulated in the 48hour knockdown versus the
control cells, were collagen catabolic process, multicellular organismal catabolic process, and
multicellular organism metabolic process (Figure 16C). These results suggest mis regulation of a
multitude of genes at a very early time following MLLT3 knockdown that affect the utilization of
lipid species within the cell, thereby affecting metabolic processes, while concomitantly
increasing extracellular interactions.
Indeed, this imbalance between lipid utilization was characterized by differential gene expression
patterns in many metabolic pathways including triglyceride formation and storage, lipid
transport, lipoprotein formation, glucose metabolism, and some transcription factors that regulate
these pathways (Figure 17). Genes significantly upregulated in the MLLT3 knockdown cells at
48 hours within these pathways include AGPAT9 (also known as GPAT3), an enzyme that
performs the first step in triglyceride formation, and NR4A1, a transcription factor known to
positively regulate lipid metabolic gene expression. However, several genes were significantly
downregulated, many of which are involved in lipid utilization and repression. These genes
include FABP1, a protein involved in binding fatty acids and lipids and transporting them
throughout the cell; APOC3, which is involved in very-low-density lipoprotein formation among
other things, a process which allows lipids to leave the hepatocyte; RORC, a repressor of
circadian rhythmic expression of lipid and glucose metabolic genes; and HMGCS2, a protein
involved in ketone body formation.
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Figure 16. RNA-Sequencing Data Reveals Differential Gene Expression Patterns in HepG2
Cells Following MLLT3 Knockdown at 48 hours. (A )Venn diagram showing the number of
differentially expressed genes comparing the HepG2 cells after 48hr MLLT3 knockdown versus
the control cells. (B) Differentially regulated cellular pathways as identified by gene ontology
pathway analysis. Pathways downregulated are on top, and pathways upregulated are shown on
the bottom. The bioinformatics analyses in this figure were performed by Novogene.
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Genes involved in the glucose anabolic pathway that were significantly downregulated at 48hrs
of MLLT3 knockdown include G6PC and PCK1, which are key enzymes involved in
gluconeogenesis (Figure 17). There was also a significant increase in extracellular matrix genes
involved in fibril formation. These include COL1A1, COL1A2, COL4A1, and COL3A1, all of
which are responsible for fibril trimer formation and extracellular matrix stiffening (Figure 17).
These results suggest a potential role for MLLT3 in the homeostatic regulation of lipid genes
involved in various processes through the cell as well as extracellular matrix-related properties.
Interestingly, certain genes differentially expressed at 48 hours following MLLT3 knockdown
were not significantly differentially expressed at 72 hours, with the exception of a smaller
number of genes. However, many genes remained significantly increased within the 72 hour
knockdown cells. The RNA-seq data greater than 1400 differentially regulated genes in the 72
hour knockdown cells compared to the vector control cells (Figure 18A). This includes hundreds
of genes differentially regulated between the 48 hour and 72 hour knockdown cells (Figure 18B).
Gene ontology data revealed that significantly altered pathways in the 72 hour knockdown cell
lines include the upregulation of extracellular matrix organization and structure, collagen
metabolic and trimer formation, and organismal metabolic process (Figure 19A). Gene ontology
revealed that pathways downregulated in the 72 hour knockdown cells include negative
regulation of fibrinolysis, carbohydrate metabolic process and glucose metabolic process (Figure
19B).
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Figure 17. Volcano Plot Highlighting Differentially Expressed Genes That are Involved in
Lipid and Glucose Metabolism and Fibril Formation Following MLLT3 Knockdown in
HepG2 Cells. Volcano plot that displays differentially expressed genes involved in lipid and
glucose metabolism and fibril formation. I plotted this data from RNA-seq data from 48 hour
HepG2 MLLT3 knockdown as compared to control cells. Some relevant genes with increased
expression following MLLT3 knockdown (red) and decreased expression following MLLT3
knockdown (green) are indicated.
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Figure 18. RNA-sequencing Data From 72 hour HepG2 MLLT3 knockdown Cells Showing
Differentially Expressed Genes as Compared to Control Cells. (A) Venn diagram displaying
differentially expressed genes between the 72 hour shMLLT3 HepG2 cells and the Vector
Control. (B) Venn diagram depicting differentially expressed genes between both the 48 hour
and the 72 hour shMLLT3 HepG2 cells and controls. The bioinformatics analyses in this figure
were performed by Novogene.
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Figure 19. Gene Ontology Graphs Displaying Significantly Changed Pathways Upon
MLLT3 Knockdown For 72 hours in HepG2 Cells. Gene ontology plots revealing in (A)
pathways that are significantly downregulated and in (B) pathways that are differentially
upregulated upon MLLT3 knockdown for 72 hours in HepG2 cells as compared to control cells.
The bioinformatics analyses in this figure were performed by Novogene.
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Significantly changed genes within the 72 hour knockdown cells again involved genes involved
in triglyceride formation, lipid storage, lipid transport, glucose metabolism, and extracellular
matrix formation. As in the shMLLT3 48 hour knockdown HepG2 cells, FABP1, APOC3,
G6PC, and PCK1, continued to be significantly downregulated in the 72 hour knockdown cells.
In addition to these genes that were significantly downregulated, APOB, a protein involved in
many lipoprotein formation pathways, was significantly downregulated within the 72 hour
knockdown cell lines, as well as, PLIN2, a gene involved in lipid droplet regulation. Genes in
the 72 hour MLLT3 knockdown cell lines that were significantly upregulated include GPAT2, an
enzyme involved in the last step of triglyceride formation; PLIN1, a protein involved in lipid
droplet formation; SPHK2, which is involved in signaling pathways which involve sphinogine-1phosphate; and the extracellular matrix collagens, COL1A1, COL1A2, COL4A1, and COL3A1
(Figure 20).
Validation of MLLT3-dependent genes expression by qRT-PCR
Genes determined to be differentially expressed from RNA-seq data were further validated by
qRT-PCR of RNA isolated from independent samples of HCC cells following in vitro MLLT3
knockdown and control cells from 48hr, 72hr, and 1 week time points. Two HCC cell lines,
HepG2 and HuH7, were used for these validation experiments. Validation of expression of
genes suggested by the HepG2 RNA-seq data, displayed similar expression patterns in the 48hr,
72hr, and 1wk HepG2 knockdown cell lines. FABP1 was decreased by 30% and 45% in the
48hr and 72hr HepG2 MLLT3 knockdown cells respectively, which is similar to the RNA-seq
data that showed FABP1 as downregulated (Figure 21A). Another gene, NR4A1, displayed
similar expression pattern to the RNA-seq data, being differentially increased in expression at
48hrs and decreased at 72hrs following MLLT3 knockdown (Figure 21A and 21B). Finally,
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LDLR, was slightly increased in expression at all time points, mimicking the data from RNA-seq
(Figure 21).

Figure 20. Volcano Plot of Differentially Expressed Genes Involved in Lipid and Glucose
Metabolism and Extracellular Matrix Formation in the 72 Hour MLLT3 Knockdown
HepG2 Cells. Volcano plot that displays differentially expressed genes involved in lipid and
glucose metabolism and extracellular matrix formation. I plotted this data from RNA-seq data
from 72 hour HepG2 MLLT3 knockdown as compared to control cells. Some relevant genes with
increased expression following MLLT3 knockdown (red) and decreased expression following
MLLT3 knockdown (green) are indicated.
Interestingly, there were genes that were differentially regulated within the qPCR analyzed data
that differ from the expression levels determined by RNA-seq. These include the increases of
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50% in SPHK1 at 48hrs and greater than 4 fold at1 week (Figure 21 A and C). Interestingly,
RNA isolated at 72hrs displayed a more than 50% decrease in expression (Figure 21B). Other
genes not significantly differentially expressed in the RNA-seq data were FASN, UCP2, RXRA,
LDLR, and MLLT1 (Figure 21B). FASN and UCP2 both had close to 2 fold increase in
expression at 48 hours, with stabilization at 72hrs, to massive 4 fold increase in FASN and 10
fold increase in UCP2 at 1 week (Figure 21C). Although this data is suggestive of a role for
MLLT3 in lipid homeostasis, these data was only generated from one independent experiment.
However, when the data is analyzed by looking at gene expression only, and not by expression at
a specific time point, the N is increased to seven. These data show that there is a significant
increase in the lipid modulating genes, SPHK1, FASN, LDLR, and in the cell stress gene UCP2
following MLLT3 knockdown (Figure 21D).
qRT-PCR expression data from HuH7 cells were analyzed using more biological
replicates at each time point for each gene, and included more genes analyzed. HuH7 MLLT3
knockdown cells at 48hrs showed a significant increase in RXRA and significant decreases in
NR4A1, FASN, SREBF1, MLLT1, SPHK1, SPHK2, and UCP2 (Figure 22A). FABP1 trended
toward being increased, but did not reach statistical significance (p=.221). In Huh7 cells with
MLLT3 knockdown for 72hr, there were significant alterations to the expression of some genes.
Specifically, SPHK1 and SPHK2 were significantly upregulated while the remainder of the genes
tested remained at similar levels as the 48hr cells (Figure 22B). Finally, in the 1wk knockdown
Huh7 cells, FABP1 is significantly upregulated by almost 4 fold. Additionally, RXRA and both
SPHK1 and SPHK2 were significantly upregulated (Figure 22C). Here, as a possible sign of
cellular stress UCP2, was significantly upregulated (Figure 22C).
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Figure 21. Gene Expression in HepG2 Cells With MLLT3 Knockdown as Compared to
Control Cells at 48hr, 72hr and 1wk. Gene expression data measured by qRT-PCR from the
HepG2 MLLT3 knockdown cells (KD) as compared to vector control cells (VC) at (A) 48hrs, (B)
72hrs, (C) one week, and (D) all time points combined. A, B, and C are from one experiment
performed in triplicate. D is from 3 timepoints, each in triplicate. Paired T-Test was performed in
(D), and * = <.05, ** = <.01, *** = <.001, and **** = <.0001. A,B, and C are an N=1. D is
N=2 for FASN and RXRA and an N=3 for MLLT3, SPHK1, FABP1, NR4A1, UCP2, LDLR, and
MLLT1
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These data suggest that MLLT3 knockdown is somehow disrupting the normal balance of gene
expression involved in lipid homeostasis and lipid dependent cell signaling. Similar analysis was
applied to expression data from HuH7 in that these genes were also looked at regardless of time
point following MLLT3 knockdown. This data indicates that there significant increases in lipid
metabolism genes FABP1 and RXRA as well as the cell stress gene UCP2 (Figure 22D). There
was also significant decreases in MLLT3, and the lipid homeostasis genes FASN and SREBF1
(Figure 22D). These results suggest that MLLT3 is regulating expression of these genes thereby
altering liver lipid homeostasis and the alterations during the various time points indicate that the
cell is responding to these changes.
Expression analysis of liver tissue isolated from liver specific-MLLT3-deletion Mice
In order to complement gene expression changes determined following in vitro MLLT3
knockdown in human HCC cell lines, qRT-PCR was also performed using RNA isolated from
livers of liver specific Albumin-Cre Mllt3 knockout mice. Liver tissue was isolated from both
male and female mice with Mllt3 deletion and age/sex matched controls at 5.3 weeks, 10 weeks,
13 weeks, and 21 weeks of age (Table 4). RNA was isolated, converted to cDNA, and was
analyzed for gene expression all of the gene targets validated in the in vitro cell lines. When
comparing gene expression data from only male knockout livers compared to wild type livers,
regardless of time point, I found significant increases in Srebf1, Col1a1, Col3a1, Mllt1, Agpat9,
while significant decreases in expression were observed for Mllt3 and G6pc (Figure 23A).
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Figure 22. HuH7 Gene Expression in MLLT3 Knockdown Cell Lines at 48hr, 72hr, and
1wk. qPCR data of gene expression from HuH7 cells at 48hr (A), 72hrs (B), 1 wk (C), and a
composite of all time points (D). (A) and (B) are two independent experiments (n=2) run in
triplicate and (C) is one experiment ran in triplicate. (D) is a combination of all time points
(n=5). A Paired T-Test was performed in (D) and the errors bars represent the SEM. * = <.05,
** = <.01, *** = <.001, and **** = <.0001. (A) displays N=2 for MLLT3, FABP1, FASN,
NR4A1, RXRA,MLLT1, SPHK1 and 2 and an N=1 for SREBF1 and UCP2. (B) Displays an N=2
for MLLT3,, FABP1, FASN, RXRA, and NR4A1 and an N=1 for MLLT1, SREBF1, SPHK1,
SPHK2, and UCP2. (C) displays an N=1 for all genes. (D) displays N=5 for MLLT3, FABP1,
FASN, NR4A1, RXRA, and MLLT3; n=5 for SPHK1 and SPHK2; n=2 for UCP2 and SREBF1.
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Figure 23. qPCR Data from Mice Albumin-Cre Liver Specific Knockout. Male (A) and
female (B) comparisons of gene expression regardless of mice age at sacrifice. N=6 for each
genotype. A Paired T-Test was performed and the errors bars represent the SEM. * = <.05, ** =
<.01, *** = <.001, and **** = <.0001. (A) displays an N=5 for Mllt3 and Srebf1; n=4 for
Col1a1, Fabp1, Agpat9, Col3a1, Col1a2, Apoc3 and Mllt1; n=3 for G6pc. (B) displays an N=7
for Mllt3, G6pc, Col1a1, Fabp1, Agpat9, and Col3a1; N=6 for Srebf1, Apoc3, Col1a2, and Mllt1
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However, this was in stark contrast when only knockout female livers were compared to control
female livers, again disregarding age, when looking at the same genes. In female livers with
Mllt3 knockout, there was only a significant increase in Srebf1 expression while significant
decreases were observed in Mllt3 and G6pc (Figure 23B). These results are suggestive of sex
differences in Mllt3-dependent expression of metabolic genes. The phenomenon of sex
differences in gene expression has been previously documented in liver tissue.
When comparing the expression data as it applied to the age of the mouse, significant
expression was observed that fluctuated as the mouse aged. When all livers from 5.3wk male
and female mice were compared to wild type 5.3wk livers, again there was significant increase in
Srebf1 while significant decreases in Mllt3, and Fabp1 were observed (Figure 24A). Comparing
10 week knockout livers to the control 10 week livers, there was a significant increase in Agpat9
and Fabp1, while significant decreases were observed in Mllt3 and G6pc (Figure 24B). When
13 week knockout livers were compared to 13 week control livers, there were not significant
increases in any of the genes analyzed, while significant decreases in Mllt3, G6pc, and Fabp1
were observed (Figure 24C). Finally, when 21 week knockout mice livers were compared to the
control counterparts there was a significant increase or decrease in every gene analyzed.
Significant increases were observed in Srebf1, Col1a1, Mllt1, Apoc3, Fabp1, and Col3a1 while
significant decreases in expression were observed for Mllt3, G6pc, and Agpat9 (Figure 24D).
Finally comparing gene expression of all livers regardless of time and sex, significant increases
in Srebf1, Col1a1, Mllt1, and Apoc3 were observed. Significant decreased Mllt3 expression was
observed, while the rest of the genes analyzed were not significantly altered (Figure 25). These
results suggest that possible sex differences exist between male and female mice.
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Figure 24. qRT-PCR Expression from Aged Matched Alb-Cre Mice. Gene Expression Data
from 5.3 week (A), 10 week (B), 13 week (C), and 21 week(D) mice Alb-Cre KO livers as
compared to the WT control. N= 2 of each genotype for (A,B,C, and D). A Paired T-Test was
performed and the errors bars represent the SEM. * = <.05, ** = <.01, *** = <.001, and **** =
<.0001. (A) Displays an n=2 for Apoc3 and all rest of genes display n=3. (B) displays an N=2
for all genes. (C) displays an N=3 for Fabp1 and Col3a1 and an N=2 for rest of genes. (D)
displays an N=2 for Agpat9, Apoc3, and G6pc and an N=3 for the remaining genes.
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Figure 25. qPCR Expression of select genes in Alb-Cre Mice Livers Regardless of Age and Sex.
qPCR Data from both male and female mice (N=12 of each genotype) on gene expression
regardless of age and sex. A Paired T-Test was performed and the errors bars represent the
SEM. * = <.05, ** = <.01, *** = <.001, and **** = <.0001. This displays an N=12 for each
genotype.
Expression of certain metabolic genes differ between sexes, while the expression of these genes
is variable at differing mouse ages. These genes, when compared to all livers, fail to reach
significance possibly due to the variable differential expression between male and female livers,
again suggestive of a sex difference in metabolic gene expression.

CHAPTER 4
DISCUSSION
My thesis research has been to determine the liver-intrinsic component of a strong phenotype
that was observed in Mllt3 whole body knockout mice created in our lab: hepatic steatosis that
progressed to NASH. MLLT3 is an epigenetic gene regulator that is recruited to target genes by
its chromatin “reader” YEATS domain, and can recruit multiple different effector complexes to
those genes. This could cause either activation or repression of MLLT3 direct target genes. Gene
dysregulation has been shown to be a hallmark of NAFLD in the development of steatosis. Liver
steatosis can lead to NASH, and eventually cirrhosis and hepatocellular carcinoma that require
liver transplantation (Cite). De novo lipogenesis genes, such as ACC1 and FASN, have been
shown to have increased expression in the liver of patients suffering from NAFLD, mainly
through increased activity of the transcription factor, SREBF1c42,43. This increase in free fatty
acids leads to increases triglyceride formation leading to increases in lipid storage, inducing
steatosis44. These triglycerides can be exported out of the cell via very-low-density-lipoproteins
(VLDL) when coupled with Apolipoprotein B and Apolipoprotein C-III or catabolized via boxidation. However, in NAFLD the activity of these processes are moderately downregulated or
are simply unable to keep with the lipid supply45. This suggests that dysregulation between lipid
acquisition (uptake or endogenous synthesis), storage and export are what defines the
development of steatosis.
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Hepatocyte-Intrinsic Role of MLLT3 to Protect From Lipid Accumulation in Liver
MLLT3 was knocked down in HepG2 and HuH7 by lentiviral transduction. Generation of the
virus took place in HEK293T cells and since the constructs possessed GFP, I was able to
determine the viral efficiency in these cells (Figure 4). Upon transduction into the in vitro cell
lines, GFP positive cells were sorted using flow cytometry which established potentially pure
colonies of MLLT3 knockdown and control cells to study(Figure 5A and Figure 7). MLLT3
knockdown efficiency was confirmed by qPCR for both cell lines (Figures 6 and 8). Upon
MLLT3 knockdown, both cell lines, HepG2, and HuH7, displayed increases in lipid
accumulation, as visualized through Oil Red O staining, compared to the vector control (Figures
9-11). The knockdown cells also displayed weaker adherence, slower proliferation, and a more
rounded up appearance (Figure 5B). Liver specific Albumin-Cre knockdown of Mllt3 was also
confirmed by qPCR and the phenotype mimics the steatosis seen in whole body Mllt3 knockout
mice (Figure 12 and Figures 13-15). Both the in vitro and in vivo data suggest that there is a
hepatocyte-specific role for MLLT3 in maintaining liver lipid homeostasis through apparent
regulation of genes functioning in many metabolic pathways. The functionality of MLLT3 is
seemingly conserved between mouse and human cells, and further study needs to be given to this
protein so that potential therapeutic options may be uncovered.
Mllt33 Regulated In vivo Gene Expression
In my research I set out to determine gene expression alterations causing the observed phenotype
in MLLT3 knockdown hepatocyte cell lines and in liver tissue from liver specific Mllt3 knockout
mice. As mentioned above, some specific gene alterations are known to occur in patients with
NAFLD, and since my in vitro and in vivo studies display a phenotype of steatosis, it suggests
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that MLLT3 may play a role in regulating gene expression in some of these pathways.
Interestingly, removal of MLLT3/Mllt3 produced gene alterations across a multitude of processes
involved in liver metabolism. These include gluconeogenesis, de novo lipogenesis, triglyceride
synthesis, lipid storage and lipid removal. In liver specific Mllt3 Albumin-Cre knockout mice
livers, Srebf1 expression was significantly increased (Figure 23, 24A,C,and D, and 25). Srebf1
codes for the Srebf1c protein, which is known to directly activate genes involved in de novo
lipogenesis. My data suggests that upon Mllt3 knockout, dysregulation of this critical
transcription factor occurs causing alterations in genes involved in this process, thereby
increasing the cellular concentrations of free fatty acids (FFAs) within the hepatocytes. My data
suggests a role by MLLT3 in maintaining proper levels of the SREBF1 transcription factor.
Interestingly, SREBF1 was found to be a direct target gene of MLLT3 in the HeLa cell line6 ,
and was confirmed as a direct Mllt3 target gene in liver tissue from our whole body Mllt3
knockout mice (NJA, CSH, NZL, unpublished). As mentioned before, FFAs have a number of
fates within the liver, and one is to be shuttled into the triglyceride forming pathway. Coupled
with the increases in Srebf1, significant increases in Agpat9, were observed in all male Mllt3
knockout mice as well as in 5.3wk and 10week age matched mice (Figure 23A and Figures 24A
and B). This suggests that increases in concentrations of FFAs within the hepatocyte led to an
increase expression of enzymes necessary for triglyceride formation, which in turn led to the
increase in lipid droplets as compared to the control mice. Interestingly, when female mice were
compared for expression of Agpat9, there was no significant differences between the control and
Mllt3 knockout livers, suggesting that there may be sex-dependent differences involved in
metabolic pathways. Indeed, it has been reported that females have a propensity to shuttle free

65
fatty acids to b-oxidation and ketone body formation, while males tend to shuttle free fatty acids
to triglyceride formation and VLDL secretion46. More investigation into this subject is necessary
to fully determine the extent of these differences with regard to Mllt3 function. Despite the sexspecific differences in Agpat9 expression, some similarities between sexes were also observed.
When looking at gene expression for a protein involved in VLDL formation and secretion,
Apoc3, there were not differences in expression in both male and females, when compared
regardless of age (Figure 23). This suggests and supports research others have shown that VLDL
secretion is relatively unaltered in patients with NAFLD45. However, when observing gene
expression from animals at varying ages, there was significant increase of Apoc3 in Mllt3
knockout mice at 21 weeks of age, concomitant with increases in Fabp1 (Figure 24D). This
suggests an accumulation of FFAs and potential removal of triglyceride particles at the later
timepoint following Mllt3 deletion.
The gluconeogenic enzyme glucose-6-phosphatase converts glucose-6-phosphate to
glucose in order for the liver to release glucose into the circulation upon fasting47 . Severe
deficiency in the expression of G6PC, the catalytic subunit of glucose-6-phophatase, leads to
Glycogen Storage Disease Type Ia (GSD1a), which is characterized by hepatic steatosis48.
Without this enzymatic reaction, glucose-6-phosphate (G6P) accumulates within the cells, which
leads to alterations in liver metabolism49. These alterations include an increase in de novo
lipogenesis and triglyceride synthesis and elongation50. Interestingly, I saw significant decreases
in this gene in both male and female Mllt3 knockout livers (Figure 23). Further, there appeared
to be a time dependent decrease when analyzing the age matched mice (Figure 24). Expression
was decreased starting at 5.3wk mice, declining significantly by 10week mice, with further
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attenuation by 13 week mice, at which point that level was relatively maintained by 21 weeks.
This low expression suggests, that Mllt3 binding at this gene normally induces its expression to
help the liver release glucose into the circulation. It also suggests that G6P may be accumulating
within the hepatocytes of the Alb-Cre KO mice which could therefore be inducing fatty acid
formation leading to increases in triglyceride storage and steatosis. Despite some of the Mllt3dependent gene alterations being consistently observed in both male and female mice, and
through the age matched comparisons, there were several genes that were either different
between both males and females or had seemingly time dependent sporadic expression which
ended up giving increased variability to the study. As mentioned before, Agpat9 had differential
expression between males and females, which has been observed in previous studies. Several
other genes showed a similar pattern. When all male Mllt3 knockout mice were compared,
significant increases were observed in Col1a1, Col3a1, and Mllt1, all of which had no expression
changes within the female. Apart from the sex differences, collagen expression in hepatocytes
has been somewhat of a controversy. Several studies concluded that hepatocytes normally
display very low expression of collagen I and collagen III and that high deposition of collagen
fibrils is due to other cells such hepatic stellate cells51,52. However, much more recently, it was
reported that in vitro EMT occurred in hepatocytes that started to express a-SMA and became
myofibroblasts53,54. Some in vivo studies have had conflicting perspectives. One study tried to
determine if there was any fibroblast markers in human explant livers, which ultimately
determined there was no correlations; another study performed lineage tracing and showed that
there was, in fact, a population of hepatocytes that underwent EMT55,56. At any rate, my data
suggests that both fibril forming collagens, I and III, are significantly increased in the Mllt3 male
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knockout livers compared to the control mice (Figure 23A). This expression differences
fluctuated when analyzed at different mouse ages, however they were consistently upregulated
following Mllt3 deletion (Figure 24). Collagen I and III are the fibril forming collagens that are
known to be very highly upregulated in fibrosis57. These fibrils participate in cell/cell adhesion,
migration, cell signaling and promoting proper liver functionality58,59. It is possible that these
increases could possibly have contributed to the increased fibrosis observed in the lab’s Mllt3
whole body knockout mice (Ding, CSH, NZL, unpublished). It is also possible that these
increases in collagen expression could help explain the odd morphological features I noticed
upon MLLT3 knockdown in in vitro cell lines. As mentioned before, both HCC cell lines,
HepG2 and HuH7, had a raised up cellular appearance; they started to clump together and they
initially had weaker adherence to the cell culture plate. It has been reported that several collagen
genes, including COL1A1, are direct targets of MLLT3 in HeLa cells as shown by ChIP-seq,
suggesting that these genes could potentially be directly bound and regulated by MLLT3 in liver
cells6. Further ChIP experimentation in our lab would need to be completed in HepG2 and
HuH7 to fully determine whether these genes are direct MLLT3 targets. In contrast to these
observations from males, liver tissue from female Mllt3 KO mice showed no differences in
expression of these collagen genes compared to the control (Figure 23B). Again, this suggests
sex differences in expression of these genes. The literature presents conflicting information
regarding gender and liver fibrosis. Some report there are no differences among male and
females during fibrotic development, while other groups have determined that hormonal
differences add an increased risk for females, yet others still, suggest a higher risk in males60-62.
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It is critical to note that all genes analyzed were significantly altered in the 21wk aged
mice, which shows values for male and females combined (Figure 24D). This dysregulation of
these genes clearly suggest regulatory functionality of Mllt3 in liver metabolic processes. The
fluctuations within the livers during these age matched mice may be revealing something about
the metabolic state of these mice due to Mllt3 knockout. This data suggests that despite the cells
in the liver attempting to achieve homeostasis within their metabolic pathways, by 21 weeks of
age, all genes that I assessed were significantly altered (Figure 24D). This is indicative of the
need to have Mllt3 present within these cells or permanent dysregulation will occur. It is
imperative for someone in our lab to further the studies with these liver-specific Mllt3 knockout
mice. Observations on older mice may shed more insight into a more dramatic role of Mllt3 in
the liver long after homeostasis is lost.

These mice could potentially display more steatosis and

a possible progression to NASH and/or carcinoma, particularly in male mice. Mllt3 must
somehow act as a sensor that may respond to metabolic intermediates or environmental signals at
different times in order to either repress or activate various genes within these pathways.
MLLT3 dependent in vitro gene expression
The gene expression data from HepG2 and HuH7 HCC cell lines suggests something about the
initial homeostatic imbalance that occurs upon MLLT3 knockdown. There are plenty of genes
that display alterations that are different between the cells with MLLT3 knockdown at 48hr, those
at 72hr cells, and for certain genes, by one week the change seems to revert back to the 48hr
status. The fluctuations of SPHK1, for example, suggest an intrinsic cellular response to MLLT3
knockdown, such that the cell was just trying to respond to abrupt, dramatic decreases in a
critical metabolism sensor (Figures 21 and 22) . This fluctuation in SPHK1 expression occurred
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in both HepG2 and HuH7 cell lines (Figure 21 and 22). The end result of enhanced de novo
lipogenesis is increased concentrations of palmitate, which is the molecule necessary to start
sphingosine synthesis63. This generates ceramide, which has been shown, at high concentrations,
to be positively correlated with NAFLD64. Ceramide also positively influences NAFLD and the
progression to NASH65. SPHK1 then eventually generates sphingosine-1-phosphate (S1P),
which is a signaling molecule and has been shown to have increased levels in mice fed a high fat
diet, to increase lipid accumulation, promote inflammation, and increased hepatic pathology66,67.
This suggests that increases in SPHK1 I observed following MLLT3 knockdown could result
from one and/or two things. First, in HeLa cells, it was reported by ChIP-seq that SPHK1 was a
direct MLLT3 target gene which could potentially be what is occurring here6 . Second, increases
in fatty acids, are inducing SPHK1 expression which in turn generates more S1P. The signaling
molecule S1P can then feedback and further exacerbate the metabolic disorder. The declined
expression, in HepG2, at 72 hours but the reclamation by one week, is suggestive of this analysis
taking place at such early time points (Figure 21 B, C and D). The cells seem to be trying to
adjust to a potentially necessary regulator being no longer present while trying to survive.
Interestingly, HuH7 cells also had a large increase in the expression of SPHK2, which had been
shown to have protective phenotype in NAFLD in which knockout mice developed steatosis
(Figure 22 B and C)68. FABP1 expression is also low at both early time points following
MLLT3 knockdown in HepG2 cells, but increased at early time points in HuH7 cells (Figures 21
A,B,D, and Figure 22). This suggests that in HepG2 cells, there are probably more cytotoxic
molecules, such as fatty acids, present in the cytoplasm inducing cellular stress, which can be
observed by the stark increases in UCP2 at both 48 hours and 1 week following MLLT3
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knockdown in HepG2 cells (Figure 21 A and C). The exact opposite is seen in HuH7 cells at 48
hours following MLLT3 knockdown where FABP1 expression is high and UCP2 expression is
low (Figure 22 A). However, at 1 week following MLLT3 knockdown, Huh7 cells displayed
high expression of both FABP1 and UCP2, which may suggest increased ROS generation or
higher concentrations of cytotoxic molecules that FABP1 simply cannot keep up with (Figure
22C). The high expression of FASN in HepG2 following MLLT3 knockdown, could be
supported by the high expression of Srebf1 following Mllt3 knockout in the mouse (Figure 21).
As a direct target of SREBF1, FASN should be increased, and therefore increases of FFAs and
triglycerides should be observed, again suggesting the role of MLLT3 in metabolic homeostasis
and potential homeostatic determinant. However, I found the opposite in the HuH7 cells, low
SREBF1 coupled with low FASN expression (Figure 22). In the future, gene expression analysis
will needed to be performed on components of lipid export mechanisms, since lipid
accumulation was seemingly occurring differently in the two different cell types. This could be
reflective of increased RXRA (Figure 22), which, with no ligand, is known to associate with
various nuclear receptors and induce repression or target genes expression, most of which are
metabolic genes69. In any case, total gene expression for the two different HCC cell lines differ
at these early timepoints following MLLT3 knockdown. For HepG2 cells, when all the data is
combined, I found significant increases in SPHK1, FASN, UCP2, and LDLR, while in the HuH7
cell line, I saw significant increases in FABP1 and RXRA, along with significant decreases in
FASN and SREBF1 expression (Figures 21D and 22D). Differences inherent to these two
different HCC cell lines could be the reason for these expression differences. The HepG2 cells
seem to be producing more FFAs while being unable to transport them around and/or remove
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them, thereby increasing lipid accumulation, whereas the HuH7 cells have increases in the
transporter FABP1, but decrease in FASN, which theoretically suggests that there should be less
FFAs in the cytosol. Regardless of these differences, the end result is the same. These cell types
have increased steatosis due to accumulations of triglycerides following MLLT3 knockdown.
More gene expression analysis needs to be performed in order to deduce the mechanism. In
HuH7 cells it could be that although there isn’t increases in FFAs, the increases in triglycerides
could potentially occur due to decreased expression of proteins needed to form VLDL and
therefore remove these accumulated triglycerides. In HepG2 cells it could be possible that the
rapid influx of FFAs and triglycerides are happening too fast for the cell to remove them, which
is seen in NAFLD patients45.
Potential role of MLLT3 in liver metabolic homeostasis
Trying to understand the potential role of MLLT3 within the liver and its regulation of metabolic
homeostasis, it is important to think about how MLLT3 functions. This protein is able to bind to
chromatin via its YEATS domain to crotonylated histone tails6,7. These post translational
modifications mark active promoters and potential enhancers, which occur on genes that are
actively being transcribed8. Therefore, the presence of MLLT3 at these genes is likely due, at
least in part, to their activation status in the cells, due to the histone modifications read by
MLLT3. Unfortunately I do not believe it is that simple. For example, on the C-terminus of
MLLT3 there is competitive binding for at least four different complexes, with two of those
complexes being repressor complexes. So it is entirely feasible that MLLT3 could be repressing
the expression of these genes in some fashion. Crotonylation hasn’t been fully characterized and
while it has been shown to mark activated genes, it isn’t known whether or not it also marks
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repressed genes, but on a different histone amino acid that hasn’t been studied yet. In addition,
MLLT3 can bind to other modifications such as acetylation and in particular, H4K20 acetylation
is associated with repression70. Due to these facts, MLLT3 could be repressing these genes
based on the metabolic environment of the cell. As mentioned before, it has been shown that
various modifications placed onto histone tails depend on the metabolic state of the cell9. So
MLLT3 could potentially function as a sensor within the cell which fluctuates between gene
repression and gene expression based on the availability of the various acyl-CoAs that are
present in the cell at that time. This could be mechanism that the cell uses in order to respond to
its metabolic state and adjust accordingly. MLLT3 may be the protein that responds to these
changes and helps modify the expression of target genes that need to be expressed at that time
while repressing the ones that are no longer needed.
In addition to these potential functions, MLLT3 could also be binding and regulating
genes that have potential enzymatic regulation functions. Proteins that are kinases,
acetyltransferase, ubiquitinases, or methyltransferases have the ability to not only transfer these
molecules to chromatin, but can also transfer these posttranslational modifications onto other
proteins and thus regulate their functions. It is possible that MLLT3 could be binding to these
types of proteins and activating or repressing their expression, so upon knockdown, there is
differential expression of these proteins which in turn could potentially modulate the
functionality of proteins within the metabolic pathways of the liver.
In conclusion, MLLT3 plays a critical function within the liver that is involved in
metabolic homeostasis. Upon MLLT3 knockout or knockdown, metabolic alterations occur that
generate lipid accumulation and altered expression of genes that are involved in multiple
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metabolic pathways including de novo lipogenesis, gluconeogenesis, triglyceride synthesis, and
lipid export. Future experiments needs to be performed in order to determine the exact
mechanism behind these alterations. ChIP experiments should be performed in vitro and in vivo
to determine direct targets of this protein in order to better characterize the functionality of
MLLT3. More gene expression analysis, upon knockdown should be performed on more
metabolic processes and regulators in order to fully understand the extent of this dysregulation.
Metabolic tests should be run on the cells to determine if mitochondrial function is affected and
to what extent. Knockout mice should be aged to see if they eventually acquire fibrosis and
possible transformation to carcinoma.
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